PWPS
ALXN

Pinnacle Wealth Planning Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,164
Closed -$338K – 2260
2020
Q4 		$338K Buy
2,164
+120
+6% +$15.4K 0.08% 173
2020
Q3 		$234K Sell
2,044
-55
-3% -$5.93K 0.08% 202
2020
Q2 		$236K Buy
+2,099
New +$223K 0.08% 193

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Wealth Planning Services's ALXN Position: Q1 2021 in Review

Pinnacle Wealth Planning Services sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 2,164 shares — an estimated $338K sold.

Pinnacle Wealth Planning Services first reported a position in ALXN in Q2 2020 and held it in 3 quarters. The position peaked at $338K in Q4 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Pinnacle Wealth Planning Services reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Pinnacle Wealth Planning Services sold 2,164 Alexion Pharmaceuticals shares in Q1 2021, an estimated $338K.
  • Pinnacle Wealth Planning Services first reported a position in Alexion Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Pinnacle Wealth Planning Services's Alexion Pharmaceuticals position peaked at $338K in Q4 2020.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2021, filed 29 Apr 2021.